IRADIMED CORPORATION has grown revenue 15% a year over three years and 22% a year over five, with earnings per share compounding at 18%. Revenue growth, 3-year annual rate: +15% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +22%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +18%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 13, FY2013 to FY2025, as filed.

IRMDIRADIMED CORPORATION

HealthcareUSD

$87.48

$67.7752 weeks$104.87

Is it growing?

Is IRMD growing?

IRADIMED CORPORATION has grown revenue 15% a year over three years and 22% a year over five, with earnings per share compounding at 18%.

+15%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +22%
Revenue growth, 5-year rate · +15% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +18%
Earnings per share, 3-year rate · revenue +15% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed